Improvements in vision‐related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis

References

• Chader GJ, Weiland J, Humayun MS. Artificial vision: needs, functioning and testing of a retinal electronic prosthesis. Prog Brain Res 2009; 175: 317–332.
   PubMed Web of Science ®Google Scholar
• Lewis PM, Ackland HM, Lowery AJ et al. Restoration of vision in blind individuals using bionic devices: a review with a focus on cortical visual prostheses. Brain Res 2015; 1595: 51–73.
   PubMed Web of Science ®Google Scholar
• Shintani K, Shechtman D, Gurwood A et al. Review and update: current treatment trends for patients with retinitis pigmentosa. Optometry 2009; 80: 384–401.
   PubMedGoogle Scholar
• Berson EL, Rosner B, Sandberg MA et al. ω‐3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 2012; 130: 707–711.
   PubMedGoogle Scholar
• Humayun MS, Dorn JD, da Cruz L et al. Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology 2012; 119: 779–788.
   PubMed Web of Science ®Google Scholar
• Ho AC, Humayun MS, Dorn JD et al. Long‐term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology 2015; 122: 1547–1554.
   PubMed Web of Science ®Google Scholar
• Geruschat DR, Richards TP, Arditi A et al. An analysis of observer‐rated functional vision in patients implanted with the Argus II retinal prosthesis system at three years. Clin Exp Optom 2016; 99: 227–232.
   PubMed Web of Science ®Google Scholar
• Misajon R, Hawthorne G, Richardson J et al. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci 2005; 46: 4007–4014.
   PubMed Web of Science ®Google Scholar
• FDA Guidance for Industry. Patient‐Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims. 2009 [cited 2016 February 25]. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
   Google Scholar
• Sugawara T, Hagiwara A, Hiramatsu A et al. Relationship between peripheral visual field loss and vision‐related quality of life in patients with retinitis pigmentosa. Eye 2010; 24: 535–539.
   PubMed Web of Science ®Google Scholar
• Burstedt M, Monestam E. Self‐reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type. Clin Ophthalmol 2010; 4: 147–154.
   Google Scholar
• Peacock S, Misajon R, Iezzi A et al. Vision and quality of life: development of methods for the VisQoL vision‐related utility instrument. Ophthalmic Epidemiol 2008; 15: 218–223.
   PubMed Web of Science ®Google Scholar
• The VisQoL scoring algorithm [cited 2015 October 28]. Available at: http://www.aqol.com.[au/index.php/scoring‐algorithms?id=138.
   Google Scholar
• Hahm B, Shin Y, Shim E et al. Depression and the vision‐related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol 2008; 92: 650–654.
   PubMed Web of Science ®Google Scholar
• Alcubierre N, Rubinat E, Traveset A et al. A prospective cross‐sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications. Health Qual Life Outcomes 2014; 12: 131.
   Web of Science ®Google Scholar
• Misajon R, Hawthorne G, Richardson J et al. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci 2005; 46: 4007–4014.
   PubMed Web of Science ®Google Scholar
• Finger RP, Tellis B, Crewe J et al. Developing the impact of vision impairment‐very low vision (IVI‐VLV) questionnaire as part of the LoVADA protocol. Invest Ophthalmol Vis Sci 2014; 55: 6150–6158.
   Web of Science ®Google Scholar
• Fenwick E, Zie J, Pesudovs K et al. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the vision and quality of life index. Clin Exp Optom 2012; 95: 362–370.
   PubMed Web of Science ®Google Scholar
• Feeny D. A utility approach to the assessment of health‐related quality of life. Med Care 2000; 38: 151–154.
   Web of Science ®Google Scholar
• Nieuwkerk P, Gisolf E, Colebunders R et al. Quality of life in adaptive‐ and non‐adaptive HIV infected patients in trial of ritonavir/saquinavir therapy. AIDS 2000; 14: 181–187.
   PubMed Web of Science ®Google Scholar
• Decat bergerot C, Cavalcanti ferreira de araujo TC. Assessment of distress and quality of life of cancer patients over the course of chemotherapy. Invest Educ Enferm 2014; 32: 216–224.
   PubMedGoogle Scholar
• Senra H, Barbosa F, Ferreira P et al. Psychological adjustment to irreversible vision loss in adults: a systematic review. Ophthalmology 2015; 122: 851–861.
   PubMed Web of Science ®Google Scholar
• Siqueira R, Messias A, Messias K et al. Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow‐derived stem cells (Reticell‐clinical trial). Stem Cell Res Ther 2015; 6: 29.
   PubMed Web of Science ®Google Scholar
• Kostova Z, Caiata‐zufferey M, Schultz PJ. The process of acceptance among rheumatoid arthritis patients in Switzerland: A qualitative study. Pain Res Manag 2014; 19: 61–68.
   PubMed Web of Science ®Google Scholar